AIM IMMUNOTECH INC.

United States
Lipscomb, Alabama, United States, 32801

Company profile

AIM IMMUNOTECH INC. company profile

AIM ImmunoTech is an immuno-pharmaceutical company based in Ocala, Florida. Its expertise is in the development of therapeutics for treating cancers and immune-deficiency disorders. As a result, they have developed strong laboratory and clinical data in relation to the development of nucleic acids and natural interferon to enhance the natural antiviral defence system of the human body and aid in the development of therapeutic products designed to treat cancer and chronic diseases. The company is committed to finding co-development partners with the capital and expertise to commercialize the many potential therapeutic aspects of Ampligen.

Business identity

Contact email
[email protected]
Phone number
(352)-448-7797
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0+
Founded
1990-01-01, Year

Headquarters

Postal code
32801
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
4
Total equity funding
$11.3M
Last funding
Post IPO Equity / $8M / 2025-07-29
Last equity funding
Post IPO Equity / $8M
Articles
189
Exited on
2019-09-03

Founders and investors

No public relation records are available.